Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS)
暂无分享,去创建一个
S. Bielack | M. Münter | T. Klingebiel | I. Leuschner | E. Koscielniak | G. Seitz | C. Vokuhl | F. Niggli | R. Ladenstein | G. Ljungman | J. Fuchs | M. Sparber-Sauer | M. Scheer | T. von Kalle | Monika Sparber-Sauer
[1] P. Meltzer,et al. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Robin L. Jones,et al. Pazopanib, a promising option for the treatment of aggressive fibromatosis , 2017, Anti-cancer drugs.
[3] L. Mariani,et al. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis , 2017, Cancer journal.
[4] C. Wittekind,et al. Neue TNM-Klassifikation der Lungentumoren , 2014, Der Pathologe.
[5] James Brierley,et al. Improving the TNM classification: Findings from a 10‐year continuous literature review , 2014, International journal of cancer.
[6] C. Mussi,et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] David W. Henry,et al. Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study , 2013, Pediatric blood & cancer.
[8] J. Habrand,et al. Desmoid Fibromatosis in Pediatric Patients: Management Based on a Retrospective Analysis of 59 Patients and a Review of the Literature , 2012, Sarcoma.
[9] A. Ferrari,et al. Aggressive fibromatosis in children: a changing approach. , 2011, Minerva pediatrica.
[10] L. Mariani,et al. Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment , 2009, Annals of Surgical Oncology.
[11] R. Schmelzle,et al. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Blay,et al. Extra-abdominal primary fibromatosis: Aggressive management could be avoided in a subgroup of patients. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] C. Fletcher,et al. Immunohistochemistry for β‐catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature , 2007 .
[14] S. Skapek,et al. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] B. Meister,et al. Treatment for soft tissue sarcoma in childhood and adolescence , 2005, Wiener klinische Wochenschrift.
[16] G. Henze,et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] L. Sobin,et al. How to improve the present TNM staging system , 1999, Cancer.
[18] D. Leung,et al. Extremity and trunk desmoid tumors , 1999, Cancer.
[19] M. Gebhardt,et al. Individualizing management of aggressive fibromatoses. , 1998, International journal of radiation oncology, biology, physics.
[20] H. Jürgens,et al. Treatment of soft tissue sarcoma in childhood and adolescence: A report of the german cooperative soft tissue sarcoma study , 1992, Cancer.
[21] P. Klinge,et al. Infantile desmoid‐type fibromatosis. Morphological features correlate with biological behaviour , 1991, The Journal of pathology.
[22] J. Reitamo,et al. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. , 1986, American journal of surgery.
[23] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[24] P. Hohenberger,et al. Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. , 2015, European journal of cancer.
[25] J. Coindre,et al. [Fourth edition of WHO classification tumours of soft tissue]. , 2015, Annales de pathologie.
[26] J. Coindre,et al. [Fourth edition of WHO classification tumours of soft tissue]. , 2015, Annales de pathologie.
[27] M. Hameed,et al. Desmoid fibromatosis in children and adolescents: a conservative approach to management. , 2013, Journal of pediatric surgery.
[28] J. Blay,et al. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] A. Zaenglein. Aggressive Fibromatosis in Children and Adolescents: The Italian Experience , 2011 .
[30] C. Fletcher,et al. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. , 2007, Histopathology.
[31] R. West,et al. Nuclear beta-catenin in mesenchymal tumors , 2005, Modern Pathology.